Marrone Bio (MBII), Elephant Vert Ink Distribution Deal
Zacks Investment Research | Sep 25, 2017 08:45AM ET
Marrone Bio Innovations, Inc. (NASDAQ:MBII) and Elephant Vert entered into a distribution deal under which the latter will develop and market two of Marrone Bio’s products namely, the biofungicide Reysana and bionematicide Majestene, in Tunisia, Morocco and Algeria.
Bionematicide Majestene protects crops from yield-robbing nematodes and is currently under the process of registration. Biofungicide Reysana is used by growers of peppers, tomatoes, cucurbits and grapes. It contains same ingredients as Marrone Bio’s Regalia Maxx Biofungicide, which is presently marketed and sold in more than 10 countries.
The two pioneering companies in the biological crop protection market have the knowledge and products to bring sustainable solutions, which can improve both quality and yield to farmers in North Africa.
Elephant Vert is a Swiss group that develops and markets biofertilizers, organic amendments, biostimulants and natural biopesticides produced in four production units. According to Elephant Vert, integration of biopesticides into crop protection programs is increasingly important for exporters of vegetables in the region and also benefits all production. The deal opens up potential development opportunities to offer growers in North Africa with a vast range of innovative, efficient and natural solutions.
Marrone Bio has underperformed the Original post
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.